NOVADOZ VALUE IN EVERY DOSE
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 12 Sept 2026)
What this means for you
Registered since 14 Jul 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87872128
- Registration number
- 6102588
- Mark type
- Design + words
- Filed
- 11 Apr 2018
- Published for opposition
- 16 Apr 2019
- Registered
- 14 Jul 2020
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations to treat infectious and parasitic diseases, neoplasms, diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism, endocrine, nutritional and metabolic diseases, mental, behavioral and neuro developmental disorders, diseases of the nervous system, diseases of the eye and adnexa, diseases of the ear and mastoid process, diseases of the circulatory system, diseases of the respiratory system, diseases of the digestive system, diseases of the skin and subcutaneous tissue, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system, pregnancy, childbirth and the puerperium, and congenital malformations, deformations and chromosomal abnormalities
Owner
- Novadoz Pharmaceuticals LLC, Piscataway, NJ, US
- Novadoz Pharmaceuticals LLC, Piscataway, NJ, US
- Novadoz Pharmaceuticals LLC, Piscataway, NJ, US
Prosecution history
- 12 Sept 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 12 Sept 2026 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 10 Sept 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 22 Jun 2026 — TEAS SECTION 8 & 15 RECEIVED
- 14 Jul 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 14 Jul 2020 — REGISTERED-PRINCIPAL REGISTER
- 11 Jun 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 10 Jun 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 28 May 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 28 May 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 27 May 2020 — ASSIGNED TO LIE
- 21 May 2020 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 12 May 2020 — ASSIGNED TO EXAMINER
- 12 Dec 2019 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 12 Dec 2019 — NON-FINAL ACTION E-MAILED